Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-28
1988-06-28
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, A61K 31505, C07D40306
Patent
active
047539445
ABSTRACT:
Novel 3-heteroarylalkyl-4-quinazolinones which are useful as inhibitors of thromboxane synthetase and/or as antihypertensive agents in the treatment of hypertension and myocardial ischemia.
REFERENCES:
patent: 3274194 (1966-09-01), Hayo
patent: 3322766 (1967-05-01), Schipper
patent: 3382246 (1968-05-01), Suter et al.
patent: 3454574 (1969-07-01), Keck et al.
patent: 3557117 (1971-01-01), Shetty
patent: 3558610 (1971-01-01), Bruer et al.
patent: 4335127 (1982-06-01), Vandenberk et al.
Kishor, et al., "Chemical Abstracts", vol. 62, 1965, col. 4471c.
Hideg, et al., "Chemical Abstracts", vol. 74, 1971, col. 88041a.
Vorga, et al., "Chemical Abstracts", vol. 84, 1976, col. 84:123b.
Hideg, et al., "Hung. Teljes", vol. 229, 1971, p. 445.
Parmar, et al., "J. Med. Chem.", vol. 10, 1967, pp. 1182-1183.
Hess, et al., "J. Med. Chem.", vol. 11, 1968, pp. 130-136.
Tomcufcik Andrew S.
Wright, Jr. William B.
American Cyanamid Company
Hollrah Glennon H.
Jackson H. G.
Raymond Robert P.
Turnipseed James H.
LandOfFree
Pharmaceutical methods of using 3-heteroarylalkyl-4-quinazolinon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical methods of using 3-heteroarylalkyl-4-quinazolinon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical methods of using 3-heteroarylalkyl-4-quinazolinon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1914782